Monkeypox Drug Tecovirimat Shows Limited Effectiveness
The antiviral drug tecovirimat has emerged as a focal point in the fight against the monkeypox virus, particularly as concerns rise about its spread across Africa.Recent clinical trial results have sparked debate over its effectiveness, especially against the clade I virus, which is known to pose a greater threat than its clade II counterpart.